T1	Claim 1 177	Androgen deprivation therapy is a common treatment in men with prostate cancer that may cause fatigue, functional decline, increased body fatness, and loss of lean body tissue.
T2	Claim 178 254	These physical changes can negatively affect health-related quality of life.
T3	Claim 255 403	Resistance exercise may help to counter some of these side effects by reducing fatigue, elevating mood, building muscle mass, and reducing body fat.
T4	Premise 934 1112	Men assigned to resistance exercise had less interference from fatigue on activities of daily living (P =.002) and higher quality of life (P =.001) than men in the control group.
T5	Premise 1113 1266	Men in the intervention group demonstrated higher levels of upper body (P =.009) and lower body (P <.001) muscular fitness than men in the control group.
T6	Premise 1267 1448	The 12-week resistance exercise intervention did not improve body composition as measured by changes in body weight, body mass index, waist circumference, or subcutaneous skinfolds.
T7	Claim 1449 1602	Resistance exercise reduces fatigue and improves quality of life and muscular fitness in men with prostate cancer receiving androgen deprivation therapy.
T8	MajorClaim 1603 1693	This form of exercise can be an important component of supportive care for these patients.
R1	Support Arg1:T4 Arg2:T7	
R2	Support Arg1:T7 Arg2:T8	
